Cite
Practical application and clinical impact of the WHO histopathological criteria on bone marrow biopsy for the diagnosis of essential thrombocythemia versus prefibrotic primary myelofibrosis.
MLA
Brousseau, Maud, et al. “Practical Application and Clinical Impact of the WHO Histopathological Criteria on Bone Marrow Biopsy for the Diagnosis of Essential Thrombocythemia versus Prefibrotic Primary Myelofibrosis.” Histopathology, vol. 56, no. 6, May 2010, pp. 758–67. EBSCOhost, https://doi.org/10.1111/j.1365-2559.2010.03545.x.
APA
Brousseau, M., Parot-Schinkel, E., Moles, M.-P., Boyer, F., Hunault, M., & Rousselet, M.-C. (2010). Practical application and clinical impact of the WHO histopathological criteria on bone marrow biopsy for the diagnosis of essential thrombocythemia versus prefibrotic primary myelofibrosis. Histopathology, 56(6), 758–767. https://doi.org/10.1111/j.1365-2559.2010.03545.x
Chicago
Brousseau, Maud, Elsa Parot-Schinkel, Marie-Pierre Moles, Françoise Boyer, Mathilde Hunault, and Marie-Christine Rousselet. 2010. “Practical Application and Clinical Impact of the WHO Histopathological Criteria on Bone Marrow Biopsy for the Diagnosis of Essential Thrombocythemia versus Prefibrotic Primary Myelofibrosis.” Histopathology 56 (6): 758–67. doi:10.1111/j.1365-2559.2010.03545.x.